Myambutol and Neuropathy - peripheral - a phase IV clinical study of FDA data

Summary:

Neuropathy - peripheral is reported as a side effect among people who take Myambutol (ethambutol hydrochloride), especially for people who are male, 60+ old, have been taking the drug for 1 - 2 years also take Rimifon, and have Pulmonary tuberculosis.

The phase IV clinical study analyzes which people have Neuropathy - peripheral when taking Myambutol. It is created by eHealthMe based on reports of 1,397 people who have side effects when taking Myambutol from the FDA, and is updated regularly.

What is Myambutol?

Myambutol has active ingredients of ethambutol hydrochloride. eHealthMe is studying from 1,399 Myambutol users. Check the latest studies of Myambutol.

What is Neuropathy - peripheral?

Neuropathy - peripheral (surface nerve damage) is found to be associated with 680 drugs and 1,007 conditions by eHealthMe. Check the latest studies of Neuropathy - peripheral.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Jul, 28, 2026

1,397 people reported to have side effects when taking Myambutol.
Among them, 16 people (1.15%) have Neuropathy - peripheral.

Could Myambutol cause Neuropathy - peripheral?

Among these 16 people:

How long have people been on Myambutol when they have Neuropathy - peripheral? *

What is the gender of people who have Neuropathy - peripheral when taking Myambutol? *

female: 25 %
male: 75 %

What is the age of people who have Neuropathy - peripheral when taking Myambutol? *

What are other drugs people take besides Myambutol? *

What are other side effects people have besides Neuropathy - peripheral? *

Hyporeflexia (a condition of below normal or absent reflexes): 4 people, 25.00%
Pain In Limb: 3 people, 18.75%
Muscle Atrophy (a decrease in the mass of the muscle): 2 people, 12.50%
Fatty Liver: 2 people, 12.50%
Fall: 2 people, 12.50%
Difficulty In Walking: 2 people, 12.50%
Cryptococcosis (potentially fatal fungal disease): 2 people, 12.50%
Blood Lactate Dehydrogenase Increased: 2 people, 12.50%
Visual Acuity Reduced (reduced clearness of vision): 1 person, 6.25%
Ultrasound Doppler Abnormal: 1 person, 6.25%

What are the existing conditions these people have? *

Pulmonary Tuberculosis (lungs tuberculosis): 4 people, 25.00%

* Approximation only. Some reports may have incomplete information.

Do you take Myambutol and have Neuropathy - peripheral?

- Check whether Neuropathy - peripheral is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Myambutol:

Myambutol (1,399 reports)

Browse all side effects of Myambutol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Neuropathy - peripheral:

Neuropathy - peripheral (680 drugs)

Browse all the conditions that are associated with Neuropathy - peripheral:

Neuropathy - peripheral (1,007 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ethambutol hydrochloride (the active ingredients of Myambutol) and Myambutol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.